Related Experiment Video
Updated: May 27, 2026

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
The management of anticoagulants perioperatively
Robert J Cerfolio1, Ayesha S Bryant
1Division of Cardiothoracic Surgery, University of Alabama at Birmingham, 703 19th Street South, ZRB 739, Birmingham, AL 35294, USA. rcerfolio@uab.edu
Abstract:
Perioperative management of anticoagulants requires one to balance the patient's risk factors for operative bleeding, the type of operation to be performed, and the patient's risk of thromboembolism. At present, no set algorithm exists for the perioperative management of all the anticoagulants. In this article, we address the perioperative management of the most commonly used anticoagulants seen in practice today, such as warfarin, heparin, dabigatran, clopidogrel, and aspirin, for the most commonly performed general thoracic operations.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Aneurysm IV: Nursing Management
Venous Thrombosis IV: Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management